
    
      This is a multi-center, randomized, placebo-controlled study to compare two doses of DR-3001
      to placebo for a 12-week treatment period. The overall duration of patient participation will
      be for approximately 19 weeks. Patients will be required to keep a daily diary record of
      study medication use and incontinence episodes
    
  